How Investors Are Reacting To SiriusXM (SIRI) Activating Its Next-Generation SXM-10 Satellite

• On August 20, 2025, Maxar Space Systems announced that the SXM-10 satellite, built for SiriusXM and launched earlier by SpaceX, has successfully completed in-orbit testing and is now fully operational, enhancing SiriusXM's satellite radio delivery capabilities to about 175 million vehicles.
• This milestone marks the activation of SiriusXM's second new satellite this year and highlights its ongoing investment in next-generation infrastructure to strengthen coverage and reliability across its vast automotive subscriber base.
• We'll explore how the operational launch of SXM-10 advances SiriusXM's technology roadmap and influences its investment thesis.

These 13 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.

Sirius XM Holdings Investment Narrative Recap

For an investor to remain confident in Sirius XM Holdings, a belief in the continued importance of in-car audio entertainment, and the company’s ability to capture value from its automotive partnerships despite slow revenue momentum, is key. The operational launch of the SXM-10 satellite bolsters infrastructure reliability and reach, but on its own it does not significantly alter the near-term catalyst of growing the subscriber base, nor does it resolve the risk from persistent subscriber shrinkage and competition from streaming. The company’s investment in satellite technology shows commitment to its core model, but structural headwinds in audio consumption habits and automotive exposure remain primary concerns.

One recent announcement closely related to this technological milestone is the July debut of SiriusXM Play, a lower-cost, ad-supported plan targeting a larger and more price-sensitive segment. Together with the SXM-10 launch, this move highlights SiriusXM’s focus on maximizing the reach and monetization of its automotive footprint, a business driver closely tied to the company’s most important catalyst for future revenue growth.

Yet, in contrast, investors should be mindful of the impact that ongoing subscriber declines and shifting listening habits could have on SiriusXM’s long-term revenue stability…

Read the full narrative on Sirius XM Holdings (it's free!)

Sirius XM Holdings is forecast to reach $8.5 billion in revenue and $1.1 billion in earnings by 2028. This outlook reflects a slight annual revenue decline of 0.1% and an earnings increase of $2.9 billion from current earnings of -$1.8 billion.

Uncover how Sirius XM Holdings' forecasts yield a $23.64 fair value, in line with its current price.

Exploring Other Perspectives

Six community valuations for Sirius XM Holdings range from US$23.64 to US$67.64, illustrating wide variation in growth assumptions. While many see potential value, the risk of subscriber losses remains a pressing concern for future performance discussed by market participants.

Explore 6 other fair value estimates on Sirius XM Holdings - why the stock might be worth just $23.64!

Build Your Own Sirius XM Holdings Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Sirius XM Holdings research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Sirius XM Holdings research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Sirius XM Holdings' overall financial health at a glance.

Seeking Other Investments?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• We've found 19 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
• Trump's oil boom is here - pipelines are primed to profit. Discover the 22 US stocks riding the wave.
• AI is about to change healthcare. These 27 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com